Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Transgene (0OCQ)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.480 0.000    0.00%
15/04 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 0.000 / 0.000
  • Day's Range: 1.480 - 1.488
Type:  Equity
Market:  United Kingdom
ISIN:  FR0005175080 
SEDOL:  B28MXR9
Transgene 1.480 0.000 0.00%

Transgene Company Profile

 
Read the Transgene company profile to learn more about the business and the management team. View Transgene facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

143

Equity Type

DRC

Transgene SA is a biopharmaceutical company. The Company designs and develops immunotherapy products to treat cancer and infectious diseases. These products use viral vectors to directly or indirectly destroy diseased cells. The Company has approximately three products in clinical development: two immunotherapy products for cancer treatment and an anti-infective immunotherapy product for chronic hepatitis B. The Company also has various other programs based on its viral vector technology in research or in pre-clinical or clinical development. The Company's activities are focused on human health and, in particular, the research and development of immunotherapy products, including therapeutic vaccines and oncolytic viruses in the field of cancer and infectious diseases. The Company's principal products include TG4010 (MVA-MUC1-IL2), Pexa-Vec (VV-TK-GM-CSF), TG6002 (VV-TK-RR-FCU1), TG1050 (Ad5-HBV) and TG4001 (MVA-HPV-IL2).

Contact Information

Address 400, boulevard Gonthier d’Andernach Parc d’innovation CS80166
Cedex Illkirch-Graffenstaden, 67405
France
Phone 33 3 88 27 91 00
Fax 33 3 88 27 91 11

Top Executives

Name Age Since Title
Alain Merieux 85 2020 Honorary Chairman
Alessandro Riva 62 2022 CEO & Chairman of the Board
James Di Santo - - Member of Scientific Advisory Board
Fabien Zoulim - - Member of Scientific Advisory Board
Sandrine Flory 53 2021 Director
Rafick-Pierre Sekaly - - Member of Scientific Advisory Board
Pierre Chambon - - Member of Scientific Advisory Board
Jean-Claude Weill - - Member of Scientific Advisory Board
Jean-Luc Belingard 75 2013 Non-Independent Director
Philippe Archinard 64 2004 Director
Pierre Coulie - - Member of Scientific Advisory Board
Christopher Walker - - Member of Scientific Advisory Board
Maya R. Said 46 2017 Independent Director
S. H. Sjoerd Van Der Burg - - Member of Scientific Advisory Board
Pedro Romero - - Member of Scientific Advisory Board
Marie-Yvonne Landel-Meunier 70 2017 Independent Director
Francesco Negro - - Member of Scientific Advisory Board
Jean-Pierre Armand - - Member of Scientific Advisory Board
John J. Nemunaitis - - Member of Scientific Advisory Board
Benoit Habert 59 2000 Independent Director
Robert Dreicer - - Member of Scientific Advisory Board
Jean-Yves Blay 61 2022 Independent Director
Gilbert M. Lenoir - - Member of Scientific Advisory Board
Carol Stuckley 68 2023 Independent Director
John C. Bell - 2023 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TRNG Price Commentary

Write your thoughts about Transgene SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email